BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31980352)

  • 1. Somatostatin analogues and the risk of post-operative pancreatic fistulas after pancreatic resection - A systematic review & meta-analysis.
    Li T; D'Cruz RT; Lim SY; Shelat VG
    Pancreatology; 2020 Mar; 20(2):158-168. PubMed ID: 31980352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.
    Schorn S; Vogel T; Demir IE; Demir E; Safak O; Friess H; Ceyhan GO
    Pancreatology; 2020 Dec; 20(8):1770-1778. PubMed ID: 33121847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis.
    Bootsma BT; Plat VD; van de Brug T; Huisman DE; Botti M; van den Boezem PB; Bonsing BA; Bosscha K; Dejong CHC; Groot-Koerkamp B; Hagendoorn J; van der Harst E; de Hingh IH; de Meijer VE; Luyer MD; Nieuwenhuijs VB; Pranger BK; van Santvoort HC; Wijsman JH; Zonderhuis BM; Kazemier G; Besselink MG; Daams F;
    Pancreatology; 2022 Apr; 22(3):421-426. PubMed ID: 35304104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of  Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials.
    Adiamah A; Arif Z; Berti F; Singh S; Laskar N; Gomez D
    World J Surg; 2019 Jul; 43(7):1788-1801. PubMed ID: 30798417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
    Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
    Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Pasireotide for Prevention of Postoperative Pancreatic Fistula in Pancreatic Surgery: a Systematic Review and Meta-analysis.
    Liu X; Pausch T; Probst P; Cui J; Wei J; Hackert T; Miao Y
    J Gastrointest Surg; 2020 Jun; 24(6):1421-1429. PubMed ID: 32207077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
    Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
    Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
    Tilak M; Tewari M; Shukla HS
    Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula.
    Dalton EC; Johns MS; Rhodes L; Merritt WT; Petrelli NJ; Tiesi GJ
    Am Surg; 2020 Dec; 86(12):1728-1735. PubMed ID: 32870029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
    Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppänen H
    Pancreatology; 2020 Jun; 20(4):757-761. PubMed ID: 32307251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula.
    Dalton EC; Johns MS; Rhodes L; Merritt WT; Petrelli NJ; Tiesi GG
    Am Surg; 2020 May; 86(5):429-436. PubMed ID: 32684027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis.
    Denbo JW; Slack RS; Bruno M; Cloyd JM; Prakash L; Fleming JB; Kim MP; Aloia TA; Vauthey JN; Lee JE; Katz MH
    J Gastrointest Surg; 2017 Apr; 21(4):636-646. PubMed ID: 28050766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pasireotide on postoperative pancreatic fistulas following distal resections.
    Vuorela T; Mustonen H; Kokkola A; Haglund C; Seppanen H
    Langenbecks Arch Surg; 2021 May; 406(3):735-742. PubMed ID: 33474568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin analogues for pancreatic surgery.
    Gurusamy KS; Koti R; Fusai G; Davidson BR
    Cochrane Database Syst Rev; 2012 Jun; (6):CD008370. PubMed ID: 22696379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery.
    Kawaida H; Kono H; Hosomura N; Amemiya H; Itakura J; Fujii H; Ichikawa D
    World J Gastroenterol; 2019 Jul; 25(28):3722-3737. PubMed ID: 31391768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative application of somatostatin analogs for pancreatic surgery-current status in Germany.
    Volk A; Nitschke P; Johnscher F; Rahbari N; Welsch T; Reißfelder C; Weitz J; Distler M; Mees ST
    Langenbecks Arch Surg; 2016 Nov; 401(7):1037-1044. PubMed ID: 27628685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review.
    Koti RS; Gurusamy KS; Fusai G; Davidson BR
    HPB (Oxford); 2010 Apr; 12(3):155-65. PubMed ID: 20590882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogues for pancreatic surgery.
    Gurusamy KS; Koti R; Fusai G; Davidson BR
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008370. PubMed ID: 23633353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial.
    Ma LW; Dominguez-Rosado I; Gennarelli RL; Bach PB; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Brennan MF; Jarnagin WR; Allen PJ
    Ann Surg; 2017 Jan; 265(1):11-16. PubMed ID: 27429029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for postoperative pancreatic fistula in the Era of pasireotide.
    Potter KC; Sutton TL; O'Grady J; Gilbert EW; Pommier R; Mayo SC; Sheppard BC
    Am J Surg; 2022 Aug; 224(2):733-736. PubMed ID: 35221100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.